• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒2与甲型流感病毒之间的病毒干扰

Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses.

作者信息

Gilbert-Girard Shella, Piret Jocelyne, Carbonneau Julie, Hénaut Mathilde, Goyette Nathalie, Boivin Guy

机构信息

Research Center of the CHU de Québec-Université Laval, Quebec City, Quebec, Canada.

出版信息

PLoS Pathog. 2024 Jul 22;20(7):e1012017. doi: 10.1371/journal.ppat.1012017. eCollection 2024 Jul.

DOI:10.1371/journal.ppat.1012017
PMID:39038029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11293641/
Abstract

Some respiratory viruses can cause a viral interference through the activation of the interferon (IFN) pathway that reduces the replication of another virus. Epidemiological studies of coinfections between SARS-CoV-2 and other respiratory viruses have been hampered by non-pharmacological measures applied to mitigate the spread of SARS-CoV-2 during the COVID-19 pandemic. With the ease of these interventions, SARS-CoV-2 and influenza A viruses can now co-circulate. It is thus of prime importance to characterize their interactions. In this work, we investigated viral interference effects between an Omicron variant and a contemporary influenza A/H3N2 strain, in comparison with an ancestral SARS-CoV-2 strain and the 2009 pandemic influenza A/H1N1 virus. We infected nasal human airway epitheliums with SARS-CoV-2 and influenza, either simultaneously or 24 h apart. Viral load was measured by RT-qPCR and IFN-α/β/λ1/λ2 proteins were quantified by immunoassay. Expression of four interferon-stimulated genes (ISGs; OAS1/IFITM3/ISG15/MxA) was also measured by RT-droplet digital PCR. Additionally, susceptibility of each virus to IFN-α/β/λ2 recombinant proteins was determined. Our results showed that influenza A, and especially A/H3N2, interfered with both SARS-CoV-2 viruses, but that SARS-CoV-2 did not significantly interfere with A/H3N2 or A/H1N1. Consistently with these results, influenza, and particularly the A/H3N2 strain, caused a higher production of IFN proteins and expression of ISGs than SARS-CoV-2. SARS-CoV-2 induced a marginal IFN production and reduced the IFN response during coinfections with influenza. All viruses were susceptible to exogenous IFNs, with the ancestral SARS-CoV-2 and Omicron being less susceptible to type I and type III IFNs, respectively. Thus, influenza A causes a viral interference towards SARS-CoV-2 most likely through an IFN response. The opposite is not necessarily true, and a concurrent infection with both viruses leads to a lower IFN response. Taken together, these results help us to understand how SARS-CoV-2 interacts with another major respiratory pathogen.

摘要

一些呼吸道病毒可通过激活干扰素(IFN)途径引发病毒干扰,从而减少另一种病毒的复制。在新冠疫情期间,为减轻新冠病毒传播而采取的非药物措施阻碍了对新冠病毒与其他呼吸道病毒合并感染的流行病学研究。随着这些干预措施的放宽,新冠病毒和甲型流感病毒现在可以共同传播。因此,表征它们之间的相互作用至关重要。在这项研究中,我们调查了奥密克戎变体与当代甲型H3N2流感毒株之间的病毒干扰效应,并与原始新冠病毒毒株和2009年甲型H1N1大流行性流感病毒进行了比较。我们用新冠病毒和流感病毒同时或间隔24小时感染人鼻气道上皮细胞。通过逆转录定量聚合酶链反应(RT-qPCR)测量病毒载量,通过免疫测定法定量干扰素-α/β/λ1/λ2蛋白。还通过逆转录液滴数字PCR测量四个干扰素刺激基因(ISG;OAS1/IFITM3/ISG15/MxA)的表达。此外,还测定了每种病毒对干扰素-α/β/λ2重组蛋白的敏感性。我们的结果表明,甲型流感,尤其是H3N2,会干扰两种新冠病毒,但新冠病毒不会显著干扰H3N2或H1N1。与这些结果一致的是,流感,尤其是H3N2毒株,比新冠病毒引发了更高水平的干扰素蛋白产生和ISG表达。新冠病毒在与流感合并感染期间诱导产生少量干扰素,并降低了干扰素反应。所有病毒对外源干扰素均敏感,原始新冠病毒和奥密克戎分别对I型和III型干扰素敏感性较低。因此,甲型流感很可能通过干扰素反应对新冠病毒产生病毒干扰。反之则不一定成立,两种病毒同时感染会导致较低的干扰素反应。综上所述,这些结果有助于我们了解新冠病毒与另一种主要呼吸道病原体的相互作用方式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/08c404fb436c/ppat.1012017.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/a4e69d9b03d2/ppat.1012017.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/5788425d51bd/ppat.1012017.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/7490e9bbc975/ppat.1012017.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/45ad4990c78a/ppat.1012017.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/32b5cdb951e7/ppat.1012017.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/08387cdd094a/ppat.1012017.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/08c404fb436c/ppat.1012017.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/a4e69d9b03d2/ppat.1012017.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/5788425d51bd/ppat.1012017.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/7490e9bbc975/ppat.1012017.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/45ad4990c78a/ppat.1012017.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/32b5cdb951e7/ppat.1012017.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/08387cdd094a/ppat.1012017.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa44/11293641/08c404fb436c/ppat.1012017.g007.jpg

相似文献

1
Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses.严重急性呼吸综合征冠状病毒2与甲型流感病毒之间的病毒干扰
PLoS Pathog. 2024 Jul 22;20(7):e1012017. doi: 10.1371/journal.ppat.1012017. eCollection 2024 Jul.
2
The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.甲型流感病毒宿主反应会干扰 SARS-CoV-2 复制
J Virol. 2022 Aug 10;96(15):e0076522. doi: 10.1128/jvi.00765-22. Epub 2022 Jul 12.
3
Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.甲型H1N1pdm09流感病毒而非呼吸道合胞病毒在人鼻上皮细胞的连续感染过程中干扰严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的复制。
Viruses. 2022 Feb 15;14(2):395. doi: 10.3390/v14020395.
4
Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.I型、II型和III型干扰素的抗病毒活性可抵消ACE2的诱导性并限制新型冠状病毒。
mBio. 2020 Sep 10;11(5):e01928-20. doi: 10.1128/mBio.01928-20.
5
Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.甲型流感病毒-严重急性呼吸综合征冠状病毒 2 型在人呼吸道上皮细胞中的病毒干扰作用及奥司他韦的逆转作用。
J Infect Dis. 2024 May 15;229(5):1430-1434. doi: 10.1093/infdis/jiad402.
6
SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.SARS-CoV-2 和甲型流感病毒在雪貂中的合并感染。
J Virol. 2022 Mar 9;96(5):e0179121. doi: 10.1128/JVI.01791-21. Epub 2021 Dec 22.
7
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.2019 年 11 月 1 日至 2020 年 2 月 29 日,来自意大利五家医院的严重急性呼吸综合征住院患者中未发现 SARS-CoV-2 证据。
PLoS One. 2021 Dec 7;16(12):e0260947. doi: 10.1371/journal.pone.0260947. eCollection 2021.
8
Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.SARS-CoV-2 与流感病毒体外共感染的相互作用及抗病毒治疗。
Virus Res. 2024 Jul;345:199371. doi: 10.1016/j.virusres.2024.199371. Epub 2024 Apr 18.
9
Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.成人住院患者中甲型流感(H1N1)和严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)单一和双重感染的临床和病毒学影响。
PLoS Negl Trop Dis. 2021 Nov 29;15(11):e0009997. doi: 10.1371/journal.pntd.0009997. eCollection 2021 Nov.
10
Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients.3 例合并感染患儿的 SARS-CoV-2 和流感病毒的抗病毒药敏性研究
Int J Infect Dis. 2024 Sep;146:107134. doi: 10.1016/j.ijid.2024.107134. Epub 2024 Jun 27.

引用本文的文献

1
Transcriptomic analysis of DENV-2-infected human dermal fibroblasts identified potential mechanisms that suppressed ZIKV replication during sequential coinfection.对登革热病毒2型(DENV-2)感染的人皮肤成纤维细胞进行转录组分析,确定了在序贯共感染期间抑制寨卡病毒(ZIKV)复制的潜在机制。
Virol J. 2025 May 22;22(1):154. doi: 10.1186/s12985-025-02769-9.
2
Influenza A virus interferes with respiratory syncytial virus in mice and reconstituted human airway epithelium.甲型流感病毒在小鼠和重建的人气道上皮细胞中干扰呼吸道合胞病毒。
Microbiol Spectr. 2025 Jun 3;13(6):e0318724. doi: 10.1128/spectrum.03187-24. Epub 2025 May 14.
3
The changing landscape of pediatric infectious diseases before, during, and after the COVID-19 pandemic.

本文引用的文献

1
SARS-CoV-2 nsp15 endoribonuclease antagonizes dsRNA-induced antiviral signaling.SARS-CoV-2 nsp15 内切核酸酶拮抗 dsRNA 诱导的抗病毒信号。
Proc Natl Acad Sci U S A. 2024 Apr 9;121(15):e2320194121. doi: 10.1073/pnas.2320194121. Epub 2024 Apr 3.
2
Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.甲型流感病毒-严重急性呼吸综合征冠状病毒 2 型在人呼吸道上皮细胞中的病毒干扰作用及奥司他韦的逆转作用。
J Infect Dis. 2024 May 15;229(5):1430-1434. doi: 10.1093/infdis/jiad402.
3
Non-Pharmacologic Interventions in COVID-19 Pandemic Management; a Systematic Review.
2019冠状病毒病大流行之前、期间及之后儿科传染病格局的变化
Child Health Nurs Res. 2025 Apr;31(2):79-84. doi: 10.4094/chnr.2025.013. Epub 2025 Apr 30.
4
Trends of respiratory viruses and factors associated with severe acute respiratory infection in patients presenting at a university hospital: a 6-year retrospective study across the COVID-19 pandemic.大学医院就诊患者中呼吸道病毒的流行趋势及与严重急性呼吸道感染相关的因素:一项跨越新冠疫情的6年回顾性研究
Front Public Health. 2025 Mar 28;13:1494463. doi: 10.3389/fpubh.2025.1494463. eCollection 2025.
5
Bacterial and Viral Coinfections in Adult Patients Hospitalized With COVID-19 Throughout the Pandemic: A Multinational Cohort Study in the EuCARE Project.整个大流行期间因COVID-19住院的成年患者中的细菌和病毒合并感染:EuCARE项目中的一项多国队列研究
J Infect Dis. 2025 Jul 11;231(6):e1091-e1101. doi: 10.1093/infdis/jiaf167.
6
Seasonal Shifts in Influenza, Respiratory Syncytial Virus, and Other Respiratory Viruses After the COVID-19 Pandemic: An Eight-Year Retrospective Study in Jalisco, Mexico.新冠疫情后流感、呼吸道合胞病毒及其他呼吸道病毒的季节性变化:墨西哥哈利斯科州的一项八年回顾性研究
Viruses. 2024 Dec 8;16(12):1892. doi: 10.3390/v16121892.
7
Respiratory pathogen dynamics in community fever cases: Jiangsu Province, China (2023-2024).社区发热病例中的呼吸道病原体动态:中国江苏省(2023-2024 年)。
Virol J. 2024 Sep 20;21(1):226. doi: 10.1186/s12985-024-02494-9.
8
Prevalence of Co-Infections in Primary Care Patients with Medically Attended Acute Respiratory Infection in the 2022/2023 Season.2022/2023 年度初级保健中因急性呼吸道感染就诊患者的合并感染发生率。
Viruses. 2024 Aug 13;16(8):1289. doi: 10.3390/v16081289.
2019冠状病毒病大流行管理中的非药物干预措施;一项系统综述
Arch Acad Emerg Med. 2023 Jul 23;11(1):e52. doi: 10.22037/aaem.v11i1.1828. eCollection 2023.
4
Comparative Evaluation of GS-441524, Teriflunomide, Ruxolitinib, Molnupiravir, Ritonavir, and Nirmatrelvir for In Vitro Antiviral Activity against Feline Infectious Peritonitis Virus.GS-441524、特立氟胺、鲁索替尼、莫努匹韦、利托那韦和奈玛特韦对猫传染性腹膜炎病毒体外抗病毒活性的比较评价
Vet Sci. 2023 Aug 9;10(8):513. doi: 10.3390/vetsci10080513.
5
Changing patterns of infectious diseases in children during the COVID-19 pandemic.儿童传染病模式在 COVID-19 大流行期间的变化。
Front Cell Infect Microbiol. 2023 Jun 29;13:1200617. doi: 10.3389/fcimb.2023.1200617. eCollection 2023.
6
How Interactions during Viral-Viral Coinfection Can Shape Infection Kinetics.病毒-病毒共感染期间的相互作用如何影响感染动力学。
Viruses. 2023 May 31;15(6):1303. doi: 10.3390/v15061303.
7
SARS-CoV-2 Evasion of the Interferon System: Can We Restore Its Effectiveness?SARS-CoV-2 逃避干扰素系统:我们能否恢复其有效性?
Int J Mol Sci. 2023 May 27;24(11):9353. doi: 10.3390/ijms24119353.
8
Epidemiology of Respiratory Infections during the COVID-19 Pandemic.新型冠状病毒肺炎大流行期间的呼吸道感染流行病学。
Viruses. 2023 May 13;15(5):1160. doi: 10.3390/v15051160.
9
Mechanisms of impairment of interferon production by SARS-CoV-2.SARS-CoV-2 损害干扰素产生的机制。
Biochem Soc Trans. 2023 Jun 28;51(3):1047-1056. doi: 10.1042/BST20221037.
10
Seesaw Effect Between COVID-19 and Influenza From 2020 to 2023 in World Health Organization Regions: Correlation Analysis.2020 年至 2023 年世界卫生组织各区域新型冠状病毒肺炎与流感之间的跷跷板效应:相关性分析。
JMIR Public Health Surveill. 2023 Jun 12;9:e44970. doi: 10.2196/44970.